Fischer Seth H. Z. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Fischer Seth H. Z. has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
Profile
Based on the SEC filing context, Fischer Seth H. Z. is identified as a Director of Esperion Therapeutics, Inc. as of the most recent filing date of 2026-06-01. The name in the filing may appear in variations such as Seth H. Z. Fischer or Seth Z. Fischer in other documents. Public biographical information beyond the SEC filing is limited in accessible sources. In the context of corporate governance, a director role at a publicly traded biopharma company typically involves oversight of strategy, governance, and risk management. There is no publicly available indication from the provided context that this person is deceased as of the filing date.
Role
Director
Notability
40/100
Board memberships
Esperion Therapeutics, Inc.
Awards & honors
Director on the board of Esperion Therapeutics, Inc. (as of 2026-06-01)
Based on the SEC filing context, Fischer Seth H. Z. is identified as a Director of Esperion Therapeutics, Inc. as of the most recent filing date of 2026-06-01. The name in the filing may appear in variations such as Seth H. Z. Fischer or Seth Z. Fischer in other documents. Public biographical information beyond the SEC filing is limited in accessible sources. In the context of …
How many SEC Form 4 filings has Fischer Seth H. Z. submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Fischer Seth H. Z.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
